Skip to main content
. 2021 May 18;10(10):2182. doi: 10.3390/jcm10102182

Table 3.

Clinical characteristics of patients enrolled in the two study groups.

Characteristic IVF
(n = 10)
Ac + IVF
(n = 8)
p-Value
Age (y) 40.00 ± 3.83 37.88 ± 3.87 p = 0.2279
BMI (kg/m2) 23.14 ± 3.81 20.69 ± 2.99 p = 0.1728
Duration of infertility (months) 48.30 ± 36.59 33.25 ± 27.06 p = 0.5310
Number of COH cycles 3.90 ± 2.56 3.38 ± 1.92 p = 0.6530
Hormone
(Basal level)
FSH (mIU/mL) 8.61 ± 8.25 17.62 ± 16.69 p = 0.2031
LH (mIU/mL) 1.80 ± 0.95 7.74 ± 8.63 p = 0.0155
E2 (pg/mL) 88.10 ± 69.62 120.86 ± 69.47 p = 0.2370
TSH (µIU/mL) 2.70 ± 1.44 2.19 ± 0.89 p = 0.6334
DHEAS (µg/dL) 139.87 ± 58.95 202.49 ± 144.60 p = 0.4082
PRL (ng/mL) 10.34 ± 5.33 9.27 ± 5.07 p = 0.5726
AMH (ng/mL) 0.44 ± 0.36 0.58 ± 0.44 p = 0.4232
Antral follicle count (Basal level) 3.80 ± 1.03 3.63 ± 0.92 p = 0.6033

Values are shown as mean ± standard deviation. Groups are compared using Wilcoxon rank-sum test. IVF, in vitro fertilization; Ac + IVF, combination of acupuncture and IVF treatment; COH, controlled ovulation hyperstimulation; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; TSH, thyroid-stimulating hormone; DHEAS, dehydroisoandrosterone sulfate; PRL, prolactin; AMH, Anti-Müllerian hormone.